These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7478616

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G, Storch S, Rickert J, Gutacker C, Koch-Brandt C.
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
    Bisgaard HC, Ton PT, Nagy P, Thorgeirsson SS.
    J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
    [Abstract] [Full Text] [Related]

  • 25. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype.
    Sadhu DN, Lundberg MS, Burghardt RC, Ramos KS.
    J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130
    [Abstract] [Full Text] [Related]

  • 26. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I, Mäkelä TP, Koskinen PJ, Alitalo K.
    Oncogene; 1995 Aug 03; 11(3):553-60. PubMed ID: 7630640
    [Abstract] [Full Text] [Related]

  • 27. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D, Polack A, Kofler E, Bornkamm GW.
    Oncogene; 1988 Oct 03; 3(4):397-403. PubMed ID: 3078949
    [Abstract] [Full Text] [Related]

  • 28. Aberrant translational control of the c-myc gene in multiple myeloma.
    Paulin FE, West MJ, Sullivan NF, Whitney RL, Lyne L, Willis AE.
    Oncogene; 1996 Aug 01; 13(3):505-13. PubMed ID: 8760292
    [Abstract] [Full Text] [Related]

  • 29. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P, Li W, Lorenzi MV, Miki T, Zakut R, Givol D, Pierce JH.
    Oncogene; 1996 Feb 15; 12(4):775-84. PubMed ID: 8632899
    [Abstract] [Full Text] [Related]

  • 31. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
    Hartl M, Reiter F, Bader AG, Castellazzi M, Bister K.
    Proc Natl Acad Sci U S A; 2001 Nov 20; 98(24):13601-6. PubMed ID: 11698665
    [Abstract] [Full Text] [Related]

  • 32. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP, Fernández-García B, García-Sanz P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marín MC, León J.
    Mol Cancer Res; 2008 Feb 20; 6(2):325-39. PubMed ID: 18314492
    [Abstract] [Full Text] [Related]

  • 33. The N-myc proto-oncogene: developmental expression and in vivo site-directed mutagenesis.
    Stanton BR, Parada LF.
    Brain Pathol; 1992 Jan 20; 2(1):71-83. PubMed ID: 1341949
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
    Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B.
    EMBO J; 1996 Jan 15; 15(2):375-82. PubMed ID: 8617212
    [Abstract] [Full Text] [Related]

  • 35. Myc family of cellular oncogenes.
    DePinho R, Mitsock L, Hatton K, Ferrier P, Zimmerman K, Legouy E, Tesfaye A, Collum R, Yancopoulos G, Nisen P.
    J Cell Biochem; 1987 Apr 15; 33(4):257-66. PubMed ID: 3034933
    [Abstract] [Full Text] [Related]

  • 36. An enhancer "core" DNA-binding and transcriptional activity is induced upon transformation of rat embryo fibroblasts.
    Halazonetis TD.
    Anticancer Res; 1992 Apr 15; 12(2):285-91. PubMed ID: 1580545
    [Abstract] [Full Text] [Related]

  • 37. Rat fibroblasts expressing high levels of human c-myc transcripts are anchorage-independent and tumorigenic.
    Pellegrini S, Basilico C.
    J Cell Physiol; 1986 Jan 15; 126(1):107-14. PubMed ID: 3944192
    [Abstract] [Full Text] [Related]

  • 38. Different usage of two polyadenylylation signals in transcription of the N-myc gene in rat tumor cells.
    Sugiyama A, Miyagi Y, Shirasawa Y, Kuchino Y.
    Oncogene; 1991 Nov 15; 6(11):2027-32. PubMed ID: 1719466
    [Abstract] [Full Text] [Related]

  • 39. A 3' truncation of myc caused by chromosomal translocation in a human T-cell leukemia is tumorigenic when tested in established rat fibroblasts.
    Aghib DF, Bishop JM.
    Oncogene; 1991 Dec 15; 6(12):2371-5. PubMed ID: 1766681
    [Abstract] [Full Text] [Related]

  • 40. The myc gene family proteins and their role in transformation and differentiation.
    Ingvarsson S.
    Semin Cancer Biol; 1990 Dec 15; 1(6):359-69. PubMed ID: 2103508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.